RBS supports Abcam Plcs acquisition of Epitomics
Royal Bank of Scotland Corporate & Instituational Banking (RBS CIB) is delighted to announce its financial support for Abcam Plc by arranging a committed £20m revolving credit facility (RCF), provided on a bilateral basis, to enable the group to finance the cross-border acquisition of Epitomics International Inc, headquartered in San Francisco, California.
14 May 2012
Headquartered in Cambridge, UK, Abcam is a global, leading online supplier of research grade antibodies and reagents, with a catalogue of over 80,000 products.
The £20m RCF from Royal Bank of Scotland was coordinated by Mark Trainor, director, Structured Finance Corporates at RBS CIB, and Ed Urbas, relationship director at RBS CIB.
"The acquisition of Epitomics is an excellent strategic fit for Abcam, adding to the strength and breadth of our business. RBS played an important role in enabling the acquisition to be delivered, and we value their continued support."
Jeff Iliffe, Abcam’s CFO
"RBS has been delighted to support Abcam since its early days, and this finance package reaffirms RBS' commitment to support the group's continued growth strategy, and we look forward to being part of the business' ongoing development."
Mark Trainor, director, Structured Finance Corporates at RBS CIB
Posted In
Tagged
Latest news
The event explored today’s ‘always on’ world and the pressure Scots face as they struggle to balance life inside and outside of work.
Primary school children in Currie, Edinburgh put on their detective hats last week to learn more about fraud and scams thanks to the Royal Bank of Scotland MoneySense programme. Les Matheson, CEO of Personal Banking, tells us why it’s so important to financially educate young people.
New card features are being rolled out from today with all cards having a notch and raised dots.